IPO Outlook For The Week: Biotechs And Oil
Bicycle Therapeutics Ltd (BCYC) will issue more than 4.33 million shares between $14 and $16 Thursday on the Nasdaq. The offering represents 100 percent of outstanding shares and is expected to bring in about $79.73 million.
The 10-year-old biotech company is advancing six programs in oncology, ophthalmology, neurology and infectious, respiratory, cardiovascular and metabolic diseases.
Ideaya Biosciences, Inc. (IDYA) will issue 5 million shares between $13 and $15 Thursday on the Nasdaq. The offering represents about 25.7 percent of outstanding shares and is expected to bring in about $86.25 million.
Founded in 2015, the oncological biotech company runs programs for solid tumors, melanoma and non-small cell lung cancer.
Peloton Therapeutics, Inc. (PLTX) will issue 9.375 million shares between $15 and $17 Thursday on the Nasdaq. The offering represents about 21.1 percent of outstanding shares and is expected to bring in about $183.3 million.
With offices in Dallas and San Francisco, the clinical-stage biotech develops an oral oncological candidate with studies in renal cell carcinoma and solid tumors.
Rattler Midstream LP (RTLR) will issue more than 33.3 million shares between $16 and $19 Thursday on the Nasdaq. The offering represents 100 percent of outstanding shares and is expected to bring in about $728.33 million.